Breaking News on Supplements, Health & Nutrition - North America EU edition | APAC edition

Report abuse about a comment

Adverse Events

In recent years, the complexity of bringing products to market has grown.

The supplement market and life science industry is a quickly evolving, innovative space with both small and established players competing to bring new, life-enhancing innovations to market.

For instance:

There are seven major opportunities for improving quality within the industry.
Finding ways to increase revenues, while maintaining compliance and high levels of product safety is essential to maintaining a competitive edge.

Serious adverse event reports related to new products use have outpaced industry growth by 8% per annum since 2001 and Quality risk is not evenly distributed across the industry.

Posted by Jon Nugent
27 April 2012 | 14h13

Please fill in the box below to tell us why you feel the post breaks our rules. When you are finished, click on "Send" so that it can be reviewed by a moderator.

Your name *
Your email *

We will not publish your email on the site

Reason *

Back to: Dan Fabricant: FDA ‘somewhat aghast’ at degree of cGMP non-compliance